Logo

23andMe: Joseph Arron

Nov 30, 2021

Joseph Arron has been appointed as CSO of 23andMe. Previously, he was VP and senior fellow of immunology research at Genentech, which he joined in 2006. In his new role, he will determine and prioritize 23andMe's therapeutic programs and indications, including drug discovery and target validation efforts. He will also lead the firm's scientific teams across multiple medical areas, including immuno-oncology, immunology, respiratory disease, and cardiovascular disease. Arron holds an MD/PhD from Cornell University Medical College and Rockefeller University and an undergraduate degree from Princeton University.

Breaking News
The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.